Amneal Pharmaceuticals, Inc. Share Price & Technical Analysis

AMRX · $12.59 (+1.37%)

Healthcare / Drug Manufacturers - Specialty & Generic

AI Score 29 · Bearish

$12.59

+1.37%

Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, India, Ireland, and internationally. The company operates through three segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers dosage forms a

Price chart

Seasonality

May has 2 positive and 3 negative years (last 5 years shown)

-3% return in May, 10% avg return in past 3 year May month.

-1% return in 2026, 73% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
269%1%-11%2%-3%-1%
255%7%-3%-8%-4%11%-4%25%5%8%16%2%59%
24-13%0%0%0%12%-7%16%19%-2%1%-2%-4%19%
2310%-5%-33%36%21%35%7%28%0%-7%10%39%140%
22-8%2%-7%-7%-8%-14%9%-37%-9%5%13%-23%-83%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 29/100

Bearish · Emerging · Neutral

Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, India, Ireland, and internationally. The company operates through three segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers dosage forms and delivery systems, which include immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, transdermal patches, and topicals. The Specialty segment develops, promotes, sells, and distributes pharmaceutical products with a focus on central nervous system and endocrine disorders, including Parkinson's disease. This segment provides Rytary, an oral capsule formulation of carbidopa-levodopa to treat Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism; Unithroid and ONGENTYS for the treatment of hypothyroidism; and CREXONT, which is use for the treatment of Parkinson's disease. The AvKARE segment offers pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. This segment also distributes bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names; and packages and distributes pharmaceuticals and vitamins to its retail and institutional customers. It sells its products through wholesalers, distributors, retail pharmacies, managed care organizations, purchasing co-ops, hospitals, government agencies, institutions, and pharmaceutical companies. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$4.01B

P/E ratio

33.97

52W high

$15.42

52W low

$7.07

Volume

1,50,864

Beta

1.32

Related stocks in Healthcare

Frequently asked questions

What is Amneal Pharmaceuticals, Inc. share price today?
Amneal Pharmaceuticals, Inc. (AMRX) last traded around $12.59 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does AMRX have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for AMRX. Download the app for real-time alerts.
How can I analyze Amneal Pharmaceuticals, Inc. stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro